ACE2 and COVID-19: Other authors observed that both ACE2 and TMPRSS2, a serine protease for spike protein priming, are expressed in human platelets, suggesting the possibility that an ACE2-dependent SARS-CoV-2 and platelet interaction is possible, with a consecutive platelet hyperactivation and thrombosis risk in COVID-19 patients [70].